X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

Office Holiday Parties Are Back, As #MeToo Concerns Surge

In the more than two years since Alyssa Milano’s tweet sparked the #MeToo movement, there have been...

Read More >

Blog: Cooley’s 2020 Life Sciences M&A Year in Review

General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was t...

Read More >

Doing Business in 2020: Courts Tackle Employment Law

Part 2: New Employment-Related Court Decisions Impacting California’s Public and Private Entities -...

Read More >

How Might Virginia’s New Legislative Trifecta Affect Employers in the Commonwealth in 2020?

In the November 2019 election Virginia gained a Democratic “trifecta”—both legislative chambers a...

Read More >

Illinois Employers Will Need To Obtain Informed Consent To Use “Interview Bots”

Artificial intelligence (AI) solutions have been touted as a way for employers to make better hiring...

Read More >

Tenth Circuit Refuses to Dismiss FLSA Suit Against Marijuana Business

The U.S. Court of Appeals for the Tenth Circuit was not persuaded that because marijuana remains ill...

Read More >